Evidence map›Paper›PMID 36097086›Full record

ArticleAIDS and behavior2023

Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States.

Teaniese L Davis, Mona Mittal, Adanna C Oragwu, Min Qi Wang, Bradley O Boekeloo

Abstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Teaniese L DavisCenter for Health Research, Kaiser Permanente Georgia, Atlanta, GA, USA.
Mona MittalDepartment of Family Science, University of Maryland School of Public Health, College Park, MD, USA.
Adanna C OragwuClinical Pharmacy , Kaiser Permanente Georgia, Atlanta, GA, USA.
Min Qi WangDepartment of Behavioral and Community Health, University of Maryland School of Public Health, 4200 Valley Dr, 20742. 301-405-2463, College Park, MD, USA.
Bradley O BoekelooDepartment of Behavioral and Community Health, University of Maryland School of Public Health, 4200 Valley Dr, 20742. 301-405-2463, College Park, MD, USA. boekeloo@umd.edu.ORCID http://orcid.org/0000-0002-4182-6613
University of Maryland, College Park · USKaiser Permanente · USKaiser Permanente Center for Health Research · US

Funding

Increasing Effective Mental Health Care for LGBT ClientsU48DP006382 · DP · UNIV OF MARYLAND, COLLEGE PARK · PI BOEKELOO, BRADLEY O · 2018 to 2023
$4.2M
National Center for Chronic Disease Prevention and Health Promotion U48 DP006382NCCDPHP CDC HHS U48 DP006382
6 · The paper itself

Abstract

Pre-Exposure Prophylaxis (PrEP) is a priority method for preventing HIV infection. This study's aims were threefold: (1) identify characteristics of members of a large health maintenance organization, Kaiser Permanente Georgia (KPGA), associated with HIV infection, (2) identify which member characteristics associated with HIV were also associated with PrEP prescription, and (3) identify which HIV-associated characteristics were associated with under- or over-prescribing of PrEP. Analysis of variables from the electronic medical record revealed that age, race, gender, mental health diagnosis, STI diagnosis, and sexual orientation were independently associated with HIV diagnosis. The same characteristics were independently associated with PrEP prescription except for race. Persons identifying as Black or unknown race, women, and/or heterosexual; and who had an STI diagnosis and/or illicit drug use had lower odds of being prescribed PrEP than of having an HIV diagnosis. The implications of these findings for improving physician identification of candidates for PrEP prescription are discussed.

Indexed as

Anti-HIV AgentsDelivery of Health Care, IntegratedHIV InfectionsPre-Exposure ProphylaxisFemaleGeorgiaHumansMalePrescriptionsAnti-HIV AgentsHIVPre-Exposure Prophylaxis (PrEP)PrescriptionPreventionProviders

Identifiers

PMID36097086
OpenAlexW4295444021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.